MV Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.9K | Buy |
305
+51
| +20% | +$3.99K | ﹤0.01% | 417 |
|
|
2025
Q1 | $18.4K | Sell |
254
-20
| -7% | -$1.45K | ﹤0.01% | 445 |
|
|
2024
Q4 | $20.3K | Buy |
274
+4
| +1% | +$296 | ﹤0.01% | 426 |
|
|
2024
Q3 | $17.8K | Sell |
270
-98
| -27% | -$6.47K | ﹤0.01% | 443 |
|
|
2024
Q2 | $34K | Buy |
368
+33
| +10% | +$3.05K | ﹤0.01% | 337 |
|
|
2024
Q1 | $32K | Sell |
335
-21
| -6% | -$2.01K | ﹤0.01% | 354 |
|
|
2023
Q4 | $27.1K | Buy |
356
+53
| +17% | +$4.04K | ﹤0.01% | 372 |
|
|
2023
Q3 | $21K | Sell |
303
-321
| -51% | -$22.2K | ﹤0.01% | 384 |
|
|
2023
Q2 | $58.9K | Buy |
624
+26
| +4% | +$2.45K | 0.01% | 275 |
|
|
2023
Q1 | $49.5K | Buy |
598
+270
| +82% | +$22.3K | 0.01% | 284 |
|
|
2022
Q4 | $24.5K | Sell |
328
-1
| -0.3% | -$75 | ﹤0.01% | 309 |
|
|
2022
Q3 | $27K | Buy |
329
+140
| +74% | +$11.5K | ﹤0.01% | 289 |
|
|
2022
Q2 | $18K | Sell |
189
-39
| -17% | -$3.71K | ﹤0.01% | 333 |
|
|
2022
Q1 | $27K | Buy |
228
+38
| +20% | +$4.5K | ﹤0.01% | 290 |
|
|
2021
Q4 | $25K | Buy |
190
+44
| +30% | +$5.79K | ﹤0.01% | 285 |
|
|
2021
Q3 | $17K | Buy |
146
+54
| +59% | +$6.29K | ﹤0.01% | 336 |
|
|
2021
Q2 | $10K | Buy |
92
+77
| +513% | +$8.37K | ﹤0.01% | 362 |
|
|
2021
Q1 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 358 |
|
|
2015
Q3 | – | Sell |
-492
| Closed | -$12K | – | 311 |
|
|
2015
Q2 | $12K | Hold |
492
| – | – | ﹤0.01% | 290 |
|
|
2015
Q1 | $12K | Hold |
492
| – | – | 0.01% | 273 |
|
|
2014
Q4 | $10K | Buy |
+492
| New | +$10K | ﹤0.01% | 289 |
|